Christophe Jean

CIK: 0001378435

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RYTM

RHYTHM PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 24, 2026
Award(A)
Stock Option (right to buy)
Direct
3.7K shares-
RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 24, 2026
Award(A)
Restricted Stock Units
Direct
2.3K shares-
RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 23, 2026
Exercise(M)
Direct
4.7K shares-
RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 24, 2025
Award(A)
Stock Option (right to buy)
Direct
7K shares-
RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 24, 2025
Award(A)
Restricted Stock Units
Direct
4.7K shares-
RYTM
RHYTHM PHARMACEUTICALS, INC.
Jun 18, 2025
Exercise(M)
Direct
4K shares-

		Type	Shares	Price		Ownership
Jun 24, 2026	RYTM RHYTHM PHARMACEUTICALS, INC.	Award(A) Stock Option (right to buy)	3,691	-	-	Direct
Jun 24, 2026	RYTM RHYTHM PHARMACEUTICALS, INC.	Award(A) Restricted Stock Units	2,324	-	-	Direct
Jun 23, 2026	RYTM RHYTHM PHARMACEUTICALS, INC.	Exercise(M)	4,712	-	$0	Direct
Jun 24, 2025	RYTM RHYTHM PHARMACEUTICALS, INC.	Award(A) Stock Option (right to buy)	7,037	-	-	Direct
Jun 24, 2025	RYTM RHYTHM PHARMACEUTICALS, INC.	Award(A) Restricted Stock Units	4,712	-	-	Direct
Jun 18, 2025	RYTM RHYTHM PHARMACEUTICALS, INC.	Exercise(M)	4,000	-	-	Direct

1-6 of 6 transactions

About JEAN CHRISTOPHE

JEAN CHRISTOPHE (SEC CIK 0001378435) files insider reports with the SEC as Director of RHYTHM PHARMACEUTICALS, INC. (RYTM).

Signal8 holds 3 ownership filings by JEAN CHRISTOPHE, all Form 4s, filed between Jun 23, 2025 and Jun 25, 2026. Those filings report 6 transactions, from Jun 18, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on JEAN CHRISTOPHE's filings is in BOSTON, MA.

Recent filings by JEAN CHRISTOPHE

Jun 24, 2026: Grants or awards of RYTM derivative securities (2 lines, Form 4, code A).
Jun 23, 2026: Option exercise of RYTM shares (Form 4, code M).
Jun 24, 2025: Grants or awards of RYTM derivative securities (2 lines, Form 4, code A).
Jun 18, 2025: Option exercise of RYTM shares (Form 4, code M).

Other insiders filing for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Meeker David P, President and CEO
Smith Hunter C, Chief Financial Officer
Joshi Manher, Chief Medical Officer
Shulman Joseph, Chief Technical Officer
Garfield Alastair, Chief Scientific Officer
Lee Jennifer Kayden, EVP, Head of North America

How to read Form 4 transaction codes